Barry Kurokawa

Barry Kurokawa

Founder at Blackriver Capital Management Ltd.

68 year
Finance
Health Technology
Consumer Services

Profile

Barry Kurokawa is the founder and CEO of Dianomi Therapeutics, Inc. since 2017.
He is also the founder of Blackriver Capital Management Ltd.
Currently, he is a Director at Eirion Therapeutics, Inc. since 2016.
Previously, he worked as a Director at AHT Corp., Managing Director at ProMed Management, Inc., Independent Non-Employee Director at Anterios, Inc., Director of Research at Schroer Capital LP, Vice President at TCW Asset Management Co. LLC, Senior Vice President at Invesco Advisers, Inc., and Equity Analyst at The Bank of California, NA.
He completed his undergraduate degree from California State University-Los Angeles and received an MBA from Loyola Marymount University in 1984.

Barry Kurokawa active positions

CompaniesPositionStart
Blackriver Capital Management Ltd. Founder -
Founder 01/01/2017
Director/Board Member 01/01/2016
All active positions of Barry Kurokawa

Former positions of Barry Kurokawa

CompaniesPositionEnd
Director/Board Member 01/01/2016
Director of Research - Equity 31/03/2012
Chief Investment Officer 31/12/2008
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Barry Kurokawa's experience

Training of Barry Kurokawa

California State University-Los Angeles Undergraduate Degree
Loyola Marymount University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Barry Kurokawa's experience

Connections

39

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies10

Finance

Health Services

Finance

Finance

Health Technology

The Bank of California, NA

Finance

Finance

Health Technology

Health Technology

Blackriver Capital Management Ltd.

See company connections
  1. Stock Market
  2. Insiders
  3. Barry Kurokawa